New study finds a genetic link between smoking and schizophrenia

It’s well known that most people with schizophrenia are also smokers, with more than 65 per cent of schizophrenics found to be users of tobacco products compared to about 20 per cent of the general population. But the connection between the two has been a point of conjecture, up until now, as a new study has found a genetic link between smoking and schizophrenia.

An international effort on the part of researchers from the United States, the Netherlands and the University of Toronto in Canada, the study used a psychiatric genome-wide association study to search through complete sets of DNA from thousands of samples in order to locate connections between genetic traits associated with schizophrenia and nicotine dependency, both of which have been shown to have genetic associations. Researchers found multiple genes related to both conditions, which supported two different but related conclusions.

On the one hand, most of the genes strongly connected to schizophrenia were not found to directly contribute to smoking behaviours in patients – indicating that one of the reasons why so many schizophrenics smoke is to self-medicate by suppressing their psychotic symptoms and improving their cognitive functioning with the use of nicotine, an explanation that has been suggested for some time by health experts.

On the other hand, genetic markers showed that the presence of schizophrenia and nicotine dependency are characterized by similar functioning of the brain’s neurotransmitters and communications between neurons, a result which indicates that smoking is a genetic risk factor for schizophrenia. “Our results supported the self-medication hypothesis. We also found evidence that schizophrenia and ND share some genetic liability,” say the study’s authors.

The Canadian Mental Health Association just concluded Mental Health Week, designated as the first week in May, with events across the country encouraging Canadians to “Get Loud” in support of mental health.

The week kicked off with a written statement from Prime Minister Justin Trudeau, who said that all Canadians need to help change the way society views mental health issues. “We all have a responsibility to raise our awareness about mental health. We must actively encourage honest and open conversations –in our homes, our workplaces, and our communities– about what mental health is and what we can do to increase our collective well-being,” said the statement.

Mr. Trudeau acknowledged all those who have spoken out publicly about their own struggles with mental health, including his own mother, Margaret Trudeau, saying, “They are true examples of courage, bravery, and resilience. Their stories help us all become more understanding, more compassionate, and more empathetic.”

Schizophrenia, a mental illness that includes symptoms of hallucinations, delusions and confused thinking, affects about one per cent of the population. While the cause is not fully understood, it’s believed to be rooted in both genetic and environmental factors, with an onset between the ages of 18 and 25 in men and between 25 and 35 in women. People who experience schizophrenia are at a higher risk for suicide -an estimated 20 to 40 per cent have attempted suicide at one time and five per cent having completed suicide. The disease is treated with antipsychotic medication and counseling.

More Cantech Science

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

3 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

3 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

3 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

4 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

4 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

4 days ago